On November 12, Geruihui reported that yifan pharmaceutical (002019.SZ) stated on the investor interaction platform that the national negotiation product this time is dinitrate oral suspension, and ginkgo leaf pill does not involve national negotiation.
亿帆医药(002019.SZ)：银杏叶丸不涉及国谈
Yifan Pharmaceutical (002019.SZ): Ginkgo leaf pill does not involve national talks.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated